Meanwhile, T2DM patients with CKD G3–5 had higher adropin levels than those with early CKD, whereas hypertensive individuals with advanced CKD, in contrast, had lower levels of adropin than those in the early stages of CKD [38,39]. This evidence concerns the gene ENHO and chronic kidney disease.